Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Braz. J. Pharm. Sci. (Online) ; 53(4): e00212, 2017. tab, graf, ilus
Article in English | LILACS | ID: biblio-889429

ABSTRACT

ABSTRACT Etodolac is a non-steroidal anti-inflammatory drug (NSAID) and approved by USFDA as a COX2 inhibitor. Although etodolac therapy provides clinical benefits, it is associated with upper gastrointestinal (GI) tract complications also. Etodolac loaded gum Katira microsphere (ELGKM) was prepared by W1/O/W2 emulsion solvent evaporation technique. The gastric irritation properties of orally administered pure etodolac, ELGKM and blank microspheres (without etodolac) were evaluated in experimental rats treated for 6 days. The stomach examination and biochemical investigation of stomach tissue of treated rats indicated that ELGKM formulation remarkably reduced ulcerogenecity as compared to pure etodolac. The anti-inflammatory activities of pure etodolac and ELGKMs were ascertained by the implantation of cotton pellets in rats for 6 days. Based on the results, ELGKMs showed significant anti-inflammatory activities (P<0.01) as compared to control group. The cotton pellets test suggested that ELGKM formulation retained more anti-inflammatory properties among the groups. The hematological changes, biochemical analysis and histopathological studies of subacute toxicity in rats revealed that ELGKM were the effective sustained release formulation in the treatment of chronic pain and inflammation. In conclusion, the physicochemical characterization, pharmacological and toxicological studies suggest that ELGKMs may represent as a potential candidate for sustained drug delivery (10-12 hours) in chronic joint pain related diseases with remarkably diminished gastrointestinal side effects.


Subject(s)
Animals , Male , Rabbits , Rats , Tragacanth/therapeutic use , Evaporation/methods , Etodolac/analysis , Etodolac/therapeutic use , Microspheres , Upper Gastrointestinal Tract/pathology
2.
Bangladesh Med Res Counc Bull ; 1998 Apr; 24(1): 6-9
Article in English | IMSEAR | ID: sea-358

ABSTRACT

Extract of Nelumbo nucifera rhizome (RNN) was used as anti-diarrheal agent to combat the diarrhea in experimental rats. The RNN extract in graded doses (100, 200, 400 and 600 mg/kg body wt.) reduced not only the frequency of defecation, wetness of fecal dropping and PGE2 induced enteropooling but also the propulsive movements of charcoal meal significantly.


Subject(s)
Administration, Oral , Animals , Antidiarrheals/therapeutic use , Atropine/therapeutic use , Cathartics/therapeutic use , Cecum/drug effects , Diarrhea/drug therapy , Dinoprostone/pharmacology , Female , Gastrointestinal Motility/drug effects , Intestinal Mucosa/drug effects , Intestinal Secretions/drug effects , Male , Parasympatholytics/therapeutic use , Phytotherapy , Plant Extracts/administration & dosage , Plant Roots/therapeutic use , Plants, Medicinal/therapeutic use , Pylorus/drug effects , Rats , Rats, Long-Evans , Tragacanth/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL